Physician Assistant, Medical · Ft Lauderdale, FL
NPI
1194826602
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6333 N Federal Hwy Ste 301-302
Ft Lauderdale, FL, 33308
Phone (954) 772-2411
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
483 services
Medicare patients, 2024
52
Average age 71
Drug cost, 2024
$6.7M
8,372 prescriptions
Company payments, 2025
$1,322
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel N Brown was code 99214 (office e&m - established), 109 times for 49 patients. In total Daniel N Brown billed 483 services in 13 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 109 | 49 | $46.18 | $5,033 |
| 36415 Venipuncture Blood Collection | Office | 56 | 40 | $8.65 | $484 |
By year: 2022 $5,668 for 185 services; 2023 $4,465 for 128 services; 2024 $12K for 483 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 56 | 40 | $8.65 | $484 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel N Brown prescribed most often to Medicare patients was Atorvastatin Calcium, with 449 prescriptions and refills. In total Daniel N Brown wrote 8,372 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 449 | 737 | 79 | $1,808 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 390 | 392 | 49 | $1.5M |
| Rosuvastatin Calcium Generic | 386 | 668 | 74 | $2,037 |
| Lisinopril Generic | 264 | 417 | 41 | $868 |
| Amlodipine Besylate Generic | 238 | 392 | 49 | $631 |
| Tivicay Dolutegravir Sodium | 229 | 229 | 31 | $557K |
| Tamsulosin Hcl Generic | 205 | 290 | 33 | $1,454 |
| Metformin Hcl Generic | 205 | 308 | 35 | $685 |
| Omeprazole Generic | 194 | 306 | 41 | $1,679 |
| Descovy Emtricitabine/Tenofov Alafenam | 194 | 200 | 27 | $432K |
| Losartan Potassium Generic | 185 | 293 | 35 | $861 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 180 | 180 | 25 | $802K |
| Zolpidem Tartrate Generic | 168 | 229 | 25 | $1,259 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 160 | 166 | 19 | $598K |
| Hydrochlorothiazide Generic | 137 | 209 | 23 | $195 |
Brand drugs: 2,494 claims; generic drugs: 5,839 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel N Brown $1,322 ($1,322 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $477.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 26 | $477 |
| Gilead Sciences, Inc. GILD | 5 | $324 |
| EMD Serono, Inc. MRK.DE | 4 | $190 |
| Madrigal Pharmaceuticals MDGL | 1 | $146 |
| Hologic Sales and Service, LLC HOLX | 3 | $74.22 |
| Theratechnologies Inc. THTX | 1 | $35.91 |
| Merck Sharp & Dohme LLC MRK | 1 | $28.6 |
| Abbvie Inc. ABBV | 1 | $27.13 |
| Napo Pharmaceuticals Inc | 1 | $20.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.